MoneyWorks4Me

Zydus Lifesciences gets EIR for transdermal manufacturing facility

01 Oct 2024 Evaluate

Zydus Lifesciences has received the EIR report from the United States Food and Drug Administration (USFDA) for the inspection conducted at its transdermal patch manufacturing facility located at Pharmez, Ahmedabad. This facility underwent an inspection from July 15 to 19, 2024 and has been classified as Voluntary Action Indicated (VAI).

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.


Peers
Company Name CMP
Sun Pharma. Inds. 1752.10
Dr. Reddys Labs. 1232.90
Cipla 1330.60
Lupin 1966.30
Zydus Lifesciences 1123.10
View more..